The phenotypic heterogeneity of these diseases ranging from congenital malformations affecting the limbs for CLS and sclerosteosis 2 to fatigability and muscle weakness for CMS suggest that LRP4 may have several specific functions acting on different organs in a timely manner. This evidence concerns the gene LRP4 and sclerosteosis.